HealthTree Cure Tour: Houston (In-Person) with Dr. Krina Patel
HealthTree Cure Tour: Houston (In-Person) with Dr. Krina Patel
Event Description
HealthTree Foundation creates innovative tools that save lives. Join us for our in person Houston workshop on May 2 to learn more about HealthTree and HealthTree Cure Hub – a powerful, free tool that helps you manage your disease and contribute to cures.
Dr. Krina Patel from MD Anderson Cancer Center will be on hand to talk about their work in myeloma and blood cancers, new ways patients can participate in research, and answer your questions.
There is no cost to attend. Registration, parking, and a light dinner are free. This meeting is open to patients with multiple myeloma, lymphoma, leukemia and MPNs.
This event will not be recorded.
Why Attend?
Learn all the ways HealthTree Cure Hub technology works for you:
Meeting Details
- Meeting date: Thursday, May 9th, 2024 at 5:30 PM
- Location: TMC Helix Park, 7255 Helix Park Avenue 77030 Houston, Hermann Hall, Floor 2
- Registration, parking, and a light dinner are free
- Please bring your laptop and any necessary passwords to open or use your computer
Questions?
For questions about registration, contact us at +1-800-709-1113 or support@healthtree.org.
For all other questions, contact curetour@healthtree.org.
Speakers & Moderators
Todd Foster is the head of Product at HealthTree, he is an IT healthcare executive who specializes in patient experience and clinical process improvements. Todd was director of Patient and Provider Experience at MD Anderson for over a decade. Prior experience includes leadership of IT development projects at Intermountain HealthCare and United HealthCare. Todd has a passion for using technology that can help patients have a better life and along the way, help to further research for a cure.
Krina Patel, MD, MSc, is Associate Professor and Center Medical Director in the Department of Lymphoma/Myeloma of the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center (MDACC) in Houston, TX. She treats only patients with plasma cell dyscrasias and is Principal Investigator for multiple ongoing phase I/II and III immune-oncology and maintenance clinical trials for myeloma patients. Her research interests include myeloma, developing cellular therapies like CAR T, and combining immunotherapy and chemotherapy in the induction, transplant, maintenance and salvage settings and she has completed significant clinical research in hematopoeitic stem cell transplantation. Dr. Patel completed her Hematology Oncology fellowship at MDACC and served as Chief Fellow. She received her MSc for a translational project she completed in the laboratory of Dr. Laurence Cooper, evaluating the combination of CAR T cells and TCR engineered cells with vaccine in in vitro and in vivo myeloma models. She served her clinical residency in internal medicine at the University of Texas UT Health in Houston, TX and earned her medical degree at the University of Texas Southwestern Medical Center in Dallas, TX.
Location
TMC Helix Park, 7255 Helix Park Avenue, Hermann Hall, Floor 2
Helix Park Ave, Houston, TX 77030, USA
Have Any Questions?
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
Get In Touch With Us
1-800-709-1113
Support@healthtree.org
Get the latest thought leadership on your Marginal Zone Lymphoma delivered straight to your inbox
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.